Aims-The choice of a prophylactic antibiotic for cataract surgery is dependent on its antibacterial activity and tissue pen- 
etration. The influence of the route and timing of administration of cefuroxime on its intraocular concentrations was examined. Methods-120 patients were recruited before cataract surgery into a prospective trial to compare the anterior chamber concentration of cefuroxime at a fixed time after adminstration by three routes. In a further 110 patients, the interval before sampling was varied in order to permit an emination of the kinetics of penetration. In another 10 patients, cefuroxime was given topically at the completion of surgery to assess the effect of a corneal wound on aqueous penetration. Cefuroxime concentrations were measured by high performance liquid chromatography on 0.2 ml samples of aqueous aspirated from the anterior chamber. Mean aqueous concentrations of cefuroxime for each group were compared using Student's t test. Results-After 25 mg cefuroxime, mean aqueous concentrations increased in the order forniceal (<0.01 jg/ml) < topical (0.18 igIml) < subconjunctival (2.31 ItgIml) when sampled [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] minutes after administration. Aqueous concentrations of cefuroxime reached a peak between 80 and 110 minutes after both forniceal and peribulbar injection but were still rising at this time after subconjunctival injection. Prophylactic antibiotics are administered to decrease the incidence of infectious endophthalmitis, but their benefits have never been proved in a controlled clinical trial.' Preoperative antibiotic therapy should theoretically reduce periorbital bacterial flora and therefore reduce autologous bacterial contamination at the time of surgery, but a large uncontrolled study only reported a small decrease in the incidence of endophthalmitis after topical chloramphenicol.' Another important action of antibiotic prophylaxis is to provide postoperative wound and intraocular antibiotic concentrations sufficient to kill any organisms introduced at the time of surgery. The choice of antibiotic should, therefore, be determined by its activity against potential pathogens of postoperative infection (Tables 1 and 2 ) and its bioavailability.
The optimum dose and route of administration of cefuroxime to the human eye are not known. This study set out (i) to compare how the route of antibiotic delivery influences intraocular penetration in uninflamed human eyes, (ii) to ascertain the dose of cefuroxime necessary to attain clinically significant aqueous levels for each route, and (iii) to determine how a corneal wound might influence cefuroxime absorption. Materials and methods The study was divided into three parts. In the first, the dose of cefuroxime given preoperatively by topical, forniceal, and subconjunctival routes was varied. Patients were assigned to each group on a consecutive basis (see Table  3 ). Aqueous levels of cefuroxime were then measured to determine a suitable fixed dose of cefuroxime for use in the second part of the study, in which samples were taken at one of four time intervals after administration. We also investigated the ocular penetration of cefuroxime by peribulbar injection in this part of the study. The doses used are given in Table  4 . In the third part of the study, topical cefuroxime was applied to the wound at completion of surgery.
DRUG DELIVERY
For topical delivery, a preservative-free solution of 50 mg/ml cefuroxime (Glaxo) was supplied by the hospital pharmacy. Each drop was assumed to have a volume of 50 , and to contain 2.5 mg cefuroxime. It was deemed impracticable to give the patient more than 10 drops (25 mg cefuroxime) by the topical route. Drops were administered at intervals of 5 minutes when more than one drop was given, the time interval before sampling being taken from the last drop. For the postoperative penetration study, five drops (12.5 mg) were placed at 5 second intervals onto the superior limbus and aqueous sampled after an interval of 3 minutes. For injection, a solution of 125 mg/ml cefuroxime in water was made up in the theatre suite immediately before administration. Subconjunctival cefuroxime was injected under the inferior bulbar conjunctiva approximately 4 (Tables 3 and 4) . Mean concentrations for these groups were compared using Student's t test.
Results
At an interval of 12-24 minutes after the administration of 25 mg cefuroxime, the mean aqueous concentration increased in the order forniceal (<0.01 jg/ml) < topical (0.18 jg/ml) < subconjunctival (2.31 pg/ml). Following the injection of 125 mg cefuroxime, the mean aqueous concentration increased in the order forniceal (0.86 ig/ml) < peribulbar (1.63 jg/ml) < subconjunctival (20.23 jg/ml). Only a subconjunctival injection of >0.5 ml cefuroxime (125 mg/ml) resulted in aqueous levels greater than 8 jg/ml (12. 33 jig/ml, 95% confidence interval 8.16-16.5 jg/ml). By the forniceal route, it was necessary to inject an impractical 2 ml cefuroxime before clinically significant aqueous levels were obtained (1.02 jg/ml, 95% confidence interval 0.18-1.86 jg/ml) (Table 3 and Fig 1) .
For all routes of administration, however, peak aqueous levels of cefuroxime occurred considerably later than 12-24 minutes after administration. For example, following topical (Tables 1 and   2 ployed ' or have studied non-human eyes.7 In rabbits, maximal aqueous levels after topically applied penicillin were reported after only 30 minutes. In contrast, the maximal aqueous levels of cefuroxime in humans are not reached for at least 1 hour after administration by all routes. These findings are similar to those reported in the human eye for topically applied prednisolone sodium phosphate, the highest mean aqueous concentrations of which were found between 90 and 240 minutes after application. Subconjunctival cefuroxime results in the attainment of rapid and sustained clinically useful aqueous concentrations which suggests that subconjunctival cefuroxime followed by intensive topical treatment would result in the rapid onset and subsequent maintenance of high aqueous levels of this antibiotic. Since cefuroxime is an organic anion secreted by the eye, it is conceivable that intraocular concentrations of cefuroxime in non-surgical situations could be enhanced by the use of probenecid.'°It is less likely to be of benefit after surgery, however, when the barrier to equilibration across the ocular coats has been compromised.
Conventionally, subconjunctival antibiotics are given at the completion of surgery, which obviates the opportunity to decrease the number of viable bacteria introduced into the eye during surgery. This may explain why most studies have failed to demonstrate any superiority for subconjunctival antibiotic administration over topical administration in preventing postoperative endophthalmitis.1" But if subconjunctival antibiotics were to be given preoperatively and thereby reduce bacterial load, the attainment of bactericidal wound and intraocular concentrations postoperatively might be compromised, as a result of antibiotic washout during irrigation and aspiration. We noted, however, that fluid blebs were still present when surgery was performed 2 hours after subconjunctival injection, suggesting that cefuroxime is relatively slowly cleared and that intraocular concentrations might rise again after surgery. Further work should therefore investigate postoperative aqueous levels of cefuroxime after preoperative subconjunctival administration.
We measured aqueous levels in the postoperative period 3 minutes after topical application to the cornea and demonstrated rapid ocular penetration. If it had been possible to sample aqueous at longer intervals after the completion of surgery or after subconjunctival administration, even higher levels might have been obtained. Cefuroxime has been demonstrated to be relatively non-toxic to the human eye" and no adverse reactions were reported with intraocular cefuroxime concentrations as high as 550 gg/ml in the rabbit eye.7 Other drugs may be more toxic, and our results suggest that detailed pharmokinetic and experimental toxicity data should be obtained before recommending the administration of any new drug to the eye in the presence of a surgical wound.
